NGM Annual Retained Earnings
-$724.01 M
-$142.38 M-24.48%
31 December 2023
Summary:
As of January 26, 2025, NGM annual retained earnings is -$724.01 million, with the most recent change of -$142.38 million (-24.48%) on December 31, 2023. During the last 3 years, it has fallen by -$425.38 million (-142.44%).NGM Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Quarterly Retained Earnings
-$724.01 M
-$27.67 M-3.97%
31 December 2023
Summary:
As of January 26, 2025, NGM quarterly retained earnings is -$724.01 million, with the most recent change of -$27.67 million (-3.97%) on December 31, 2023. Over the past year, it has dropped by -$94.73 million (-15.05%).NGM Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.5% | -15.1% |
| 3 y3 years | -142.4% | -142.4% |
| 5 y5 years | -391.9% | -391.9% |
NGM Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +446.3% | +393.5% |
NGM Biopharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$724.01 M(+24.5%) | -$724.01 M(+4.0%) |
| Sept 2023 | - | -$696.34 M(+4.3%) |
| June 2023 | - | -$667.54 M(+6.1%) |
| Mar 2023 | - | -$629.28 M(+8.2%) |
| Dec 2022 | -$581.63 M(+38.8%) | -$581.63 M(+6.7%) |
| Sept 2022 | - | -$545.20 M(+9.5%) |
| June 2022 | - | -$497.94 M(+10.3%) |
| Mar 2022 | - | -$451.42 M(+7.7%) |
| Dec 2021 | -$418.97 M(+40.3%) | -$418.97 M(+7.0%) |
| Sept 2021 | - | -$391.73 M(+8.0%) |
| June 2021 | - | -$362.87 M(+11.2%) |
| Mar 2021 | - | -$326.18 M(+9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | -$298.63 M(+52.3%) | -$298.63 M(+10.3%) |
| Sept 2020 | - | -$270.64 M(+12.4%) |
| June 2020 | - | -$240.88 M(+11.9%) |
| Mar 2020 | - | -$215.26 M(+9.7%) |
| Dec 2019 | -$196.14 M(+33.3%) | -$196.14 M(+8.8%) |
| Sept 2019 | - | -$180.20 M(+6.4%) |
| June 2019 | - | -$169.29 M(+4.7%) |
| Mar 2019 | - | -$161.62 M(+9.8%) |
| Dec 2018 | -$147.19 M(+0.3%) | -$147.19 M(-4.3%) |
| June 2018 | - | -$153.84 M(+4.9%) |
| Dec 2017 | -$146.70 M(+10.7%) | -$146.70 M |
| Dec 2016 | -$132.54 M | - |
FAQ
- What is NGM Biopharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual retained earnings year-on-year change?
- What is NGM Biopharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly retained earnings year-on-year change?
What is NGM Biopharmaceuticals annual retained earnings?
The current annual retained earnings of NGM is -$724.01 M
What is the all time high annual retained earnings for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual retained earnings is -$132.54 M
What is NGM Biopharmaceuticals annual retained earnings year-on-year change?
Over the past year, NGM annual retained earnings has changed by -$142.38 M (-24.48%)
What is NGM Biopharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of NGM is -$724.01 M
What is the all time high quarterly retained earnings for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly retained earnings is -$146.70 M
What is NGM Biopharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, NGM quarterly retained earnings has changed by -$94.73 M (-15.05%)